Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants
A monoclonal antibody (C3) produced against foot-and-mouth disease virus type O1Caseros was found to neutralize quadrivalent monoclonal antibody escape mutant (G67) of foot-and-mouth disease virus type O1Kaufbeuren. This mutant had been characterized at the sequence level as having distinct changes affecting four non-overlapping neutralizable sites. The C3 monoclonal antibody was used to prepare a quintuple escape mutant from the G67 and a single escape mutant from the parental O1Kaufbeuren viruses. Polyclonal postvaccinated and infected cattle sera as well as polyclonal mouse and guinea-pig sera, which neutralized the quadrivalent mutant, no longer neutralized the quintuple mutant, indicating that a fifth site had been identified and that changing the fifth site eliminated all neutralization. The site was characterized using serological techniques and found to be conformationally dependent, trypsin-sensitive and independent of sites previously characterized by monoclonal antibodies. Amino acid sequencing comparing parental, single C3 and quintuple mutants showed that a single change from a glutamine to a histidine, at amino acid 149 in the structural protein VP1, (1D) characterized the C3 mutation. The fifth site probably represents a conformational epitope which is formed due to the interaction of the VP1 loop region with other surface amino acids.
HaresnapeJM,
McCahonD.
1983; Four independent antigenic determinants on the capsid polypeptides of aphthovirus.. Journal of General Virology 64:2345–2355
KärberG.
1931; Beitrag zur kollektiven behandlung pharmakologischer Reihenversuche.. Archiv für experimentelle Pathologie und Pharmakologie 162:480–483
KitsonJDA,
McCahonD,
BelshamGJ.
1990; Sequence analysis of monoclonal antibody resistant mutants of type O foot-and-mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites.. Virology 179:26–34
KnowlesNJ.
1990; A method for direct nucleotide sequencing of foot-and-mouth disease virus RNA for epidemiological studies.. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Lindholm, Denmark25–29June1990 appendix 06–112 Rome: FAO;
McCahonD,
CrowtherJR,
BelshamGJ,
KitsonJDA,
DuchesneM,
HaveP,
MeloenRH,
MorganDO,
De SimoneF.
1989; Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants.. Journal of General Virology 70:639–645
McCulloughKC,
CrowtherJR,
ButcherRN.
1985; Alteration in antibody reactivity with foot-and-mouth disease virus (FMDV) 146S antigen before and after binding to a solid phase or complexing with specific antibody.. Journal of Immunological Methods 82:91–100
OuldridgeEJ,
BarnettPV,
ParryNR,
SyredA,
HeadM,
RweyamamuMM.
1984; Demonstration of neutralizing and non-neutralizing epitopes on the trypsin-sensitive site of foot-and-mouth disease virus.. Journal of General Virology 65:2033–2040
ParryN,
FoxG,
RowlandsD,
FryS,
AcharyaR,
LoganD,
StuartD.
1990; Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus.. Nature, London 347:569–572
SamuelAR,
KnowlesNJ,
SamuelGD,
CrowtherJR.
1991; Evaluation of a trapping ELISA for the differentiation of foot-and-mouth disease virus using monoclonal antibodies.. Biologicals 19:299–310
SangerF,
NicklenS,
CoulsonAR.
1977; DNA sequencing with chain-terminating inhibitors.. Proceedings of the National Academy of Sciences, U.S.A. 74:5463–5467
XieQC,
McCahonD,
CrowtherJR,
BelshamGJ,
McCulloughKC.
1987; Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.. Journal of Virology 68:1637–1647
Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants